FRAGMIN - THE NEW GENERATION ANTITHROMBOTIC AGENT - PREFACE

被引：0
|
作者：
SAKURAGAWA, N
MAMMEN, EF
KAKKAR, VK
机构：
[1] WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,SCH MED,DEPT PHYSIOL,DETROIT,MI 48201
[3] WAYNE STATE UNIV,SCH MED,DEPT OBSTET & GYNECOL,DETROIT,MI 48201
[4] MOTT CTR,DETROIT,MI 48201
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1990年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：U1 / U1
页数：1
相关论文
共 50 条
  • [1] Fondaparinux: A new antithrombotic agent
    Cheng, JWM
    CLINICAL THERAPEUTICS, 2002, 24 (11) : 1757 - 1769
  • [2] NEW ANTITHROMBOTIC AGENT, CILOSTAZOL - INTRODUCTION
    MIYAZAKI, Y
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-2 (7A): : 1116 - 1116
  • [3] HIRUDIN - CHANCES FOR A NEW ANTITHROMBOTIC AGENT
    BREDDIN, HK
    INNERE MEDIZIN, 1991, 18 (05) : 118 - 120
  • [4] Comparison of xiaogansu with Fraxiparine and Fragmin on antithrombotic effect in rat in vivo
    Zhongguo Yaoxue Zazhi/Chinese Pharmaceutical Journal, 1999, 34 (01):
  • [5] Bivalirudin: a new generation antithrombotic drug
    Scatena, R
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (05) : 1119 - 1127
  • [6] A NEW HEPARIN TYPE ANTICOAGULANT AND ANTITHROMBOTIC AGENT
    MARX, R
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1956, 6 (11): : 667 - 674
  • [7] Fucosylated chondroitin sulfate as a new oral antithrombotic agent
    Fonseca, Roberto J. C.
    Mourao, Paulo A. S.
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (06) : 822 - 829
  • [8] Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent
    Walenga, JM
    Jeske, WP
    Samama, MM
    Frapaise, FX
    Bick, RL
    Fareed, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (03) : 397 - 407
  • [9] RECOMBINANT VWF FRAGMENT, A NEW ARTERIAL ANTITHROMBOTIC AGENT
    SCHREIBER, A
    PRIOR, C
    HRINDA, M
    COOK, J
    PERRONE, M
    UZAN, A
    RUGGERI, Z
    M S-MEDECINE SCIENCES, 1992, 8 (10): : 1036 - 1042
  • [10] Antithrombotic agents - Preface
    Ahn, HS
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28)
12345